Wellbiotec Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was KRW 0.00001 million compared to KRW 0.00001 million a year ago. Net income was KRW 3,684.25 million compared to net loss of KRW 2,077.42 million a year ago.

Basic earnings per share from continuing operations was KRW 63 compared to basic loss per share from continuing operations of KRW 44 a year ago. Diluted earnings per share from continuing operations was KRW 63 compared to diluted loss per share from continuing operations of KRW 44 a year ago. Basic earnings per share was KRW 63 compared to basic loss per share of KRW 44 a year ago.